During the past decade, Royal Marsden Hospital; Pediatric Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Royal Marsden Hospital; Pediatric Unit" are "Acute Lymphoblastic Leukemia (ALL)" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "High Grade Glioma" (1 trials), "Neuroblastoma" (1 trials) and "Sarcoma" (1 trials). Many other conditions were trialed in "Royal Marsden Hospital; Pediatric Unit" in a lesser frequency.

Most popular intervention types in "Royal Marsden Hospital; Pediatric Unit" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Cyclophosphamide" (1 trials), "Cytarabine" (1 trials) and "Fludarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Marsden Hospital; Pediatric Unit" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Royal Marsden Hospital; Pediatric Unit". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Royal Marsden Hospital; Pediatric Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Marsden Hospital; Pediatric Unit, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".